Stocktoria

iSpecimen Inc. ISPC

Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-06-17

iSpecimen Inc. statistics & valuation

Market cap$3.8M
P / S2.0×
P / B1.2×
Net margin-543.7%
FCF margin-219.9%
Return on capital-272%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-56.80% -80.50% -98.50% -111.80% -134.50% -543.70% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-29.40% -53.20% -97.90% -112.50% -137.00% -465.40% 202020212022202320242025
Return on equity (%)
-30.10% -50.40% -113.90% -377.50% -339.60% 202020212022202320242025
Shares outstanding
936213 8.7M 8.9M 454169 1.7M 4.6M 202020212022202320242025
Net debt ($)
-$24.3M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-74.90% -25.10% -41.60% -70.20% -133.70% -110.00% 202020212022202320242025
Free cash flow margin (%)
-3.50% -95.80% -58.00% -58.70% -89.30% -219.90% 202020212022202320242025
Debt / equity (×)
0.11× 202020212022202320242025
EPS ($)
-$4.97 -$2.09 -$1.16 -$24.55 -$17.58 -$2.28 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-465.4%-137.0%-112.5%-97.9%-53.2%-29.4%
Net margin-543.7%-134.5%-111.8%-98.5%-80.5%-56.8%
FCF margin-219.9%-89.3%-58.7%-58.0%-95.8%-3.5%
Return on assets-110.0%-133.7%-70.2%-41.6%-25.1%-74.9%
Return on equity-339.6%-377.5%-113.9%-50.4%-30.1%17.1%
Debt / equity————0.11×—
Current ratio1.120.621.364.6013.150.16

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.